WELCOME TO SANTA MONICA CLINICAL TRIALS

Santa Monica Clinical Trials is a private clinical research site located in Los Angeles, California. Our Investigators have over 20 years of experience and engaged in numerous phase II-IV clinical research trials, including drug and medical device studies. Participation does not require proof of medical insurance. All trials are conducted under FDA guidance and regulations.

If you or a loved one suffers from a sleep disorder, take the next step and contact a member of our study team today!  No medical insurance needed. Compensation for time & travel may be available.

OBSTRUCTIVE SLEEP APNEA 

Obstructive Sleep Apnea (OSA) is the most common and serious sleep disorder that affects approximately 20 million people in the United States. The purpose of this study is to evaluate the safety and efficacy of an investigational medication in participants with obstructive sleep apnea.

EXCESSIVE DAYTIME SLEEPINESS IN PATIENTS WITH PRADER-WILLI SYNDROME

Prader-Willi Syndrome (PWS) is a rare complex genetic disorder characterized by a myriad of symptoms including short stature, hypotonia, hyperphagia, early onset childhood obesity, excessive daytime sleepiness, and cognitive dysfunction. The purpose of this study is to evaluate the safety and efficacy of the study drug compared with a  placebo in treating excessive daytime sleepiness in patients with Prader-Willi Syndrome.

SLEEP DISTURBANCES IN INDIVIDUALS WITH AUTISM SPECTRUM DISORDER

Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder that is associated with persistent deficits in social communication, restricted/repetitive behaviors, among other symptoms. Sleep disruption in individuals with ASD is higher than in healthy controls with a documented prevalence of up to 80%. The purpose of this study is to evaluate the effectiveness and safety of the study medication on sleep in individuals with autism spectrum disorder.

DELAYED SLEEP-WAKE PHASE DISORDER

Delayed sleep–wake phase disorder (DSWPD) is a chronic dysregulation of a person's circadian rhythm (biological clock), compared to those of the general population and societal norms.  People with DSWPD generally fall asleep some hours after midnight and have difficulty waking up in the morning. However, they find it very difficult to wake up in time for a typical school or work day. If they are allowed to follow their own schedules, e.g. sleeping from 4:00 am to 1:00 pm, their sleep is improved and they may not experience excessive daytime sleepiness. The purpose of this study is to evaluate the efficacy and safety of an investigational medication compared to placebo for this condition.

NARCOLEPSY

Narcolepsy is a neurological disorder that affects an individual's control of sleep and wakefulness. People with narcolepsy experience excessive daytime sleepiness and intermittent, uncontrollable episodes of falling asleep during the daytime. The purpose of this study is to learn how well the study drug works and how safe the study drug is compared with a placebo in treating narcolepsy with cataplexy or narcolepsy without cataplexy.